Patents Represented by Attorney, Agent or Law Firm Kathleen S. Hall
  • Patent number: 6372956
    Abstract: The present invention features transgenic rodent models for HIV, wherein the transgenic rodent or transgenic rodent cell has incorporated into its genome genes encoding a human CD4 receptor and a human chemokine receptor. In particular the invention relates to transgenic rats, or mice characterized by being susceptible to infection with HIV, capable of expressing HIV structural genes, or HIV replication. The transgenic rodent or rodent cell of this invention is useful for studying the molecular basis of HIV infection, replication and pathogenicity, as well as for the testing of agents for new antiviral or vaccine strategies.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: April 16, 2002
    Assignee: The J. David Gladstone Institutes
    Inventors: Mark A. Goldsmith, Roberto F. Speck, Robert E. Atchison, Oliver Keppler
  • Patent number: 6306826
    Abstract: Heart failure following myocardial infarction is treated by administration of an angiotensin II inhibitor for 8-12 weeks, followed by administration of a growth hormone for 1-3 weeks.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: October 23, 2001
    Assignee: The Regents of the University of California
    Inventors: John Ross, Jr., Kenneth R. Chien